As the pharmaceutical industry shifts from small-molecule "pills" to large-molecule "biologics" (like antibodies), the tools used to manufacture these drugs have become a major sector.

Bioprocessing tools include large-scale Bioreactors where genetically engineered cells produce therapeutic proteins. The trend in 2026 is "Single-Use Technology" (SUT). Instead of large, permanent stainless-steel tanks that require expensive cleaning and sterilization, manufacturers use giant, sterile plastic bags. This allows for "flexible manufacturing," where a factory can switch from producing a cancer drug to a flu vaccine in a single day, simply by swapping out the plastic liners.